Dr. Sheetal Sumat Acharya, MD

Dr. Acharya practices at UP Health System - Marquette in Marquette, Michigan, part of Lifepoint Health.

Dr. Acharya's NPI, 1932128097, was assigned on July 19, 2006. Dr. Acharya holds Michigan license 4301086286.

Dr. Acharya's primary practice is UP Health System - Marquette, at 850 W Baraga Ave, Marquette, MI 49855 in Marquette County. The practice phone is (906) 228-9440.

Dr. Acharya's primary practice is UP Health System - Marquette in Marquette, Michigan, part of Lifepoint Health. Dr. Acharya is also affiliated with UP Health System - Bell. The medical group on file is UP Medical Group, Marquette | Family Medicine. Dmand AI also links Dr. Acharya to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Acharya practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Acharya's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Acharya is licensed in Michigan.

CMS data shows 643 Medicare services from Dr. Acharya across 5 procedure codes in 2024, for 259 Medicare patients. Medicare paid $56,321 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 259 Medicare patients who saw Dr. Acharya in 2024. The largest group is 65 to 74, with 132 patients. 71% of them have high blood pressure, and 66% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Acharya's median patient age at 74, with 59% women.

In 2024, Dr. Acharya wrote 847 Medicare Part D claims for 215 patients. 83% of them were for generic drugs. CMS names the drug for 645 of them, across 19 drugs with 11 or more claims each, at $1,009,952 in total drug cost. In 2023, CMS named 579 claims across 19 drugs.

Dr. Acharya accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Acharya as offering telehealth.

Dmand AI links 5 papers to Dr. Acharya, published from 2014 to 2025. 2023 was the busiest year, with 2. Dr. Acharya has published most often in Cureus. Dr. Acharya's most frequent co-authors are Jie He, MD, Rimas Vincas Lukas, MD and Heber Macmahon, MD.

Dmand AI links Dr. Acharya to 10 clinical trials, 7 of them phase 3 studies. 9 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Breast Neoplasms. National Cancer Institute (NCI) sponsors the most, 5.

CMS Open Payments shows 4 general payments to Dr. Acharya from 4 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 77% of the total. CooperSurgical, Inc. paid the most, $64.